Skip to Content

'
Mariela Blum Murphy, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd Box 426
Unit Number: 426
Houston, TX 77030-4009
Room Number: FC10.3032
Phone: 713-792-2828
Fax: 713-563-0540

Education & Training

Degree-Granting Education

2003 Universidad Catolica Santiago de Guayaquil, Guayaquil, Ecuador, MD, Doctor in Medicine and Surgery

Postgraduate Training

7/2008-7/2011 Clinical Fellowship, Hematology-Oncology, Baylor College of Medicine, Houston, TX
6/2005-6/2008 Clinical Residency, Internal Medicine, University of Miami/Jackson Memorial Hospital, Miami, FL

Board Certifications

11/2011 Medical Oncology
8/2008 Internal Medicine

Experience/Service

Institutional Committee Activities

Member, Cancer Therapeutics Committee, 6/2012-present

Professional Memberships

American Society of Clinical Oncology, Houston, TX
Junior Member, 1/2009-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Taketa T, Sudo K, Wadhawa R, Blum MM, Ajani JA. Adjuvant Therapy in Gastric Cancer: What Is The Optimal Approach? Curr Oncol Rep. e-Pub 1/26/2013. PMID: 23355076.
2. Blum MA, Takashi T, Suzuki A, Ajani JA. Management of localized gastric cancer. J Surg Oncol. e-Pub 1/9/2013. PMID: 23303654.
3. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with esophageal cancer. Eur J Cancer 48(18):3396-404, 12/2012. e-Pub 7/31/2012. PMID: 22853875.
4. Blum MA, Suzuki A, Taketa T, Ajani JA. Current therapeutic approaches to localized carcinoma of the esophagus and gastroesophageal junction. Clinical Practice Vol 9(No 4):463-471, 7/2012.
5. Blum MA, Ajani JA. Therapy: Localized gastric cancer-a CLASSIC shift in the paradigm? Nat Rev Gastroenterol Hepatol 9(4):194-5, 4/2012. e-Pub 3/6/2012. PMID: 22392288.
6. Ajani JA, Blum MA, Estrella JS, Das P, Fournier KF. Gastric Cancer: Apples Will Always Be Apples. J Clin Oncol 30(9):1017-8, 3/20/2012. e-Pub 2/13/2012. PMID: 22331947.
7. Hayashi Y, Blum MA, Ajani JA. Advanced gastroesophageal carcinoma: an update on the current therapeutic landscape. Onkologie 35(4):204-9, 2012. e-Pub 3/15/2012. PMID: 22488092.
8. Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized Gastric Cancer Treated with Chemoradation without Surgery: UTMD Anderson Cancer Center Experience. Oncology 82(6):347-351, 2012. e-Pub 6/2012. PMID: 22677933.
9. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for Prognostication of Outcome in Patients with Esophageal and Gastroesophageal Carcinoma Undergoing Definitive Chemoradiotherapy. Oncology 82(2):108-113, 2012. e-Pub 2/2012. PMID: 22328056.
10. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation. Oncology 83(5):300-304, 2012. e-Pub 9/4/2012. PMID: 22964903.
11. Blum MA, Suzuki A, Taketa T, Ajani J. The role of S-1 in the treatment of Gastric Cancer. Gastrointestinal Cancer: Targets and Therapy 1(1):59-67, 12/2011.
12. Blum M, Suzuki A, Ajani JA. A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma. Future Oncol 7(6):715-26, 6/2011. PMID: 21675835.
13. Blum MA, Ajani JA. Many a mickle makes a muckle. Translating a gastric cancer phenotype into a bigger thing. Onkologie 34(10):499-500, 2011. e-Pub 9/16/2011. PMID: 21985847.

Editorials

1. Blum MA, Ajani JA. Chemoradiation: Gastro-oesophageal cancer-is CROSSing over so hard to do? Nat Rev Clin Oncol 9(9):493-4, 9/2012. e-Pub 7/2012. PMID: 22825372.
2. Blum Murphy MA, Taketa T, Sudo K, Lee JH, Ajani JA. Surveillance for esophageal cancer: does it make sense? J Natl Compr Canc Netw 10:1590-92, 2012.

Abstracts

1. Blum MA, Hayashi Y, Xiao L, Suzuki,A, Sabloff B, Maru DM, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Swisher S, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with esophageal cancer (EC). 2012 ASCO Annual Meeting (#e14547), 6/2012.
2. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Maru D, Rice DC, Hofstetter WL, Erasmus JJ, Swisher S, Ajani JA. Nomograms for prognostication of patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. J Clin Oncol 4(82) (#6), 1/2012.
3. Taketa T, Correa AM, Suzuki A, Blum MA, Lee JE, Welsh J, Lin SH, Maru D, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Swisher S, Wayne Lewis Hofstetter WL, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer (EC) patients who declined surgery after preoperative chemoradiation. J Clin Oncol 4(6) (#82), 1/2012.
4. Lara M Paraskos, Mariela A. Blum, Maricer Escalon, Annapoorna Ferrell, Erin Kobetz, and Joseph Rosenblatt. Defining Outcomes in Hispanic Aggressive Non-Hodgkin Lymphoma Patients. Blood 114(4542), 11/2009.

Book Chapters

1. Blum M, and Lynch G. Neuroendocrine Tumors. In: Tumor Board Review: Guidelines and Case Reviews in Clinical Oncology, 2011. ISBN: 9781936287178.

Letters to the Editor

1. Ajani JA, Blum MA, Welsh J, Hofstetter WL, Swisher SG. Celebrate or calibrate? We say calibrate. J Clin Oncol 29(19):2732; author reply 2732-3, 7/1/2011. e-Pub 5/23/2011. PMID: 21606421.

Last updated: 12/5/2013